More News

03 Nov 2016 NBE Therapeutics Raises CHF 20 Million in Series B Funding
03 Nov 2016 Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs
03 Nov 2016 Actelion obtains an option to in-license vamorolone from ReveraGen
03 Nov 2016 Biotest AG will offer recombinant factor VIII from 2017
02 Nov 2016 Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals
02 Nov 2016 Verastem Licenses Duvelisib from Infinity Pharmaceuticals
02 Nov 2016 MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatology
01 Nov 2016 miRagen Therapeutics and Signal Genetics Sign Merger Agreement
31 Oct 2016 Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma
31 Oct 2016 Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma
28 Oct 2016 Astellas to Acquire Ganymed Pharmaceuticals
27 Oct 2016 Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC, Expanding Innovative Gastroenterology Pipeline
26 Oct 2016 Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma
26 Oct 2016 Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC Announce U.S. Licensing Agreement for MorphaBond™ Formulated with SentryBond™ Abuse-Deterrent Technology
26 Oct 2016 WILEX AG: Subsidiary Heidelberg Pharma and Nordic Nanovector Enter into Collaboration to Develop Novel Antibody Drug Conjugates (ADC)
25 Oct 2016 Relief Therapeutics Holding AG and FirstString Research Inc. Announce a Strategic Collaboration for the Development of Atexakin Alfa
25 Oct 2016 Selexis SA Inks Commercial Cell Line License Agreement with ImmuNext, Inc. for Anti-CD40L Antibody Being Developed for Treatment of Chronic Autoimmune Disorders
25 Oct 2016 Fimbrion and GSK to Develop Novel Antibacterial Therapy for Urinary Tract Infections
24 Oct 2016 Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement to Include New Combination Product for Pain and Nausea
23 Oct 2016 NeuroVive and Arbutus sign termination agreement
20 Oct 2016 Debiopharm International SA Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer in Cancer Immunotherapy
20 Oct 2016 SOTIO and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates
20 Oct 2016 Synaffix Enters into a Commercial License Agreement with ADC Therapeutics
20 Oct 2016 TxCell and University of British Columbia start collaboration to develop CAR Tregs in solid organ transplantation
20 Oct 2016 Cerulean Announces Technology Platform Collaboration

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top